1 tracked superinvestor hold Xenon Pharmaceuticals Inc (XENE), worth $14M combined, led by Stanley Druckenmiller. Smart money is accumulating XENE as of the latest 13F filings.
Current price
$70.96
+109.0%
1Y
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener,…
Market cap
$4.4B
P/E
-12.87
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$85
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$14M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating XENE: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
Xenon Pharmaceuticals Inc (XENE) is held by 1 tracked funds worth $14M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Stanley Druckenmiller), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.4% | $14M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own XENE?
1 tracked funds hold Xenon Pharmaceuticals Inc (XENE), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.4% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling XENE?
In the most recent 13F quarter, 1 tracked fund added or opened XENE and 0 trimmed it, including 1 brand-new position.
How much XENE do tracked funds hold?
Combined disclosed long exposure to XENE across tracked superinvestors is $14M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.